ATE114114T1 - Verwendung von benzimidazol-derivaten als antibakterielle mittel. - Google Patents

Verwendung von benzimidazol-derivaten als antibakterielle mittel.

Info

Publication number
ATE114114T1
ATE114114T1 AT90301256T AT90301256T ATE114114T1 AT E114114 T1 ATE114114 T1 AT E114114T1 AT 90301256 T AT90301256 T AT 90301256T AT 90301256 T AT90301256 T AT 90301256T AT E114114 T1 ATE114114 T1 AT E114114T1
Authority
AT
Austria
Prior art keywords
antibacterial agents
benzimidazole derivatives
stands
hydrogen
campylobacter
Prior art date
Application number
AT90301256T
Other languages
English (en)
Inventor
Tomoyuki Iwahi
Hiroshi Satoh
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26370930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE114114(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE114114T1 publication Critical patent/ATE114114T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
AT90301256T 1989-02-10 1990-02-06 Verwendung von benzimidazol-derivaten als antibakterielle mittel. ATE114114T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3237489 1989-02-10
JP23923389 1989-09-15

Publications (1)

Publication Number Publication Date
ATE114114T1 true ATE114114T1 (de) 1994-12-15

Family

ID=26370930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90301256T ATE114114T1 (de) 1989-02-10 1990-02-06 Verwendung von benzimidazol-derivaten als antibakterielle mittel.

Country Status (10)

Country Link
US (1) US5013743A (de)
EP (1) EP0382489B1 (de)
AT (1) ATE114114T1 (de)
CA (1) CA2009741C (de)
DE (1) DE69014141T2 (de)
DK (1) DK0382489T3 (de)
ES (1) ES2066120T3 (de)
FI (2) FI100168B (de)
GR (1) GR3014973T3 (de)
NO (1) NO900639L (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338723A (en) * 1989-10-13 1994-08-16 Merck & Co., Inc. Fibrinogen receptor antagonists
JPH06500547A (ja) * 1990-09-14 1994-01-20 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング ピリジルメチルスルフィニル―１ｈ―ベンゾイミダゾール誘導体のヘリコバクターにより起こされる病気の治療のための使用
TW209174B (de) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
TW276996B (de) * 1992-04-24 1996-06-01 Astra Ab
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
CA2138787A1 (en) * 1992-07-08 1994-01-20 Clifton Augustus Baile Alleviating stomach ulcers in swine
EP0652751B1 (de) * 1992-07-28 1996-10-23 Astra Aktiebolag Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten
EP0585722B1 (de) * 1992-08-21 1996-05-15 Eisai Co., Ltd. Benzimidazolverbindungen als Antibiotika gegen Campylobacter pylon
AU5699594A (en) * 1992-12-10 1994-07-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Use of alkylthiopyridines for controlling helicobacter bacteria
JPH06298611A (ja) * 1993-04-16 1994-10-25 Nippon Chemiphar Co Ltd 抗菌剤
PL178477B1 (pl) * 1993-06-29 2000-05-31 Byk Gulden Lomberg Chem Fab Nowe związki, pochodne arylotioalkilotiopirydyny, oraz sposób ich wytwarzania i lek zawierający te związki
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE69918799D1 (de) 1998-01-14 2004-08-26 Uab Res Foundation Birmingham Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
FI104384B (fi) 1998-06-05 2000-01-14 Valmet Corp Laitteisto ja menetelmä viiraveden ja tuoremassan sekoittamiseksi viirakaivon jälkeisessä kanavassa
CA2419067C (en) * 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali
EP1428825A4 (de) * 2001-09-18 2005-03-23 Zeria Pharm Co Ltd Benzimidazolderivate
US9358214B2 (en) * 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
WO2004073654A2 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
EP1648417A4 (de) * 2003-07-18 2010-01-20 Santarus Inc Pharmazeutische formulierung und verfahren zur behandlung von säurebedingten gastrointestinalen erkrankungen
EP1648416A4 (de) * 2003-07-18 2012-03-28 Santarus Inc Pharmazeutische formulierungen zur hemmung der säuresekretion und herstellungs- und anwendungsverfahren
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
WO2005076987A2 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
JP2007532677A (ja) * 2004-04-16 2007-11-15 サンタラス インコーポレイティッド プロトンポンプ阻害剤、緩衝剤、および運動促進薬の組み合わせ
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
WO2006047493A2 (en) * 2004-10-21 2006-05-04 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
EP1934201A1 (de) * 2005-10-06 2008-06-25 Auspex Pharmaceuticals Inc. Deuterierte hemmer von gastrischer h+, k+-atpase mit verstärkten therapeutischen eigenschaften
KR101348643B1 (ko) * 2006-03-10 2014-01-08 링크 제노믹스 가부시키가이샤 항 헬리코박터피로리 작용을 가지는 신규 피리딘 유도체
EP2026768B1 (de) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Pharmazeutische formulierung auf mehreren einheiten
EP2023721A2 (de) * 2006-06-05 2009-02-18 Auspex Pharmaceuticals Inc. Herstellung und verwendung substituierter erythromycin-analoge
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
GB2459393B (en) 2006-10-05 2010-09-08 Santarus Inc Novel capsule formulation for the proton pump inhibitor omeprazole
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
RU2484089C1 (ru) * 2009-04-09 2013-06-10 Ариджен Фармасьютикалз, Инк. Тиопроизводное пиридина и фармацевтическая композиция, которая его содержит и имеет способность действовать против helicobacter pylori
CN102958515A (zh) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
AR079862A1 (es) * 2010-01-08 2012-02-22 Eurand Inc Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JP2694361B2 (ja) * 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤

Also Published As

Publication number Publication date
ES2066120T3 (es) 1995-03-01
NO900639L (no) 1990-08-13
FI104045B1 (fi) 1999-11-15
FI100168B (fi) 1997-10-15
CA2009741A1 (en) 1990-08-10
CA2009741C (en) 1999-03-23
FI900662A0 (fi) 1990-02-09
FI940951L (fi) 1994-02-28
GR3014973T3 (en) 1995-05-31
NO900639D0 (no) 1990-02-09
FI940951A0 (fi) 1994-02-28
DE69014141T2 (de) 1995-05-24
DE69014141D1 (de) 1994-12-22
EP0382489B1 (de) 1994-11-17
EP0382489A3 (de) 1991-06-12
FI104045B (fi) 1999-11-15
DK0382489T3 (da) 1995-01-16
EP0382489A2 (de) 1990-08-16
US5013743A (en) 1991-05-07

Similar Documents

Publication Publication Date Title
ATE114114T1 (de) Verwendung von benzimidazol-derivaten als antibakterielle mittel.
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
NZ228893A (en) Substituted quinoline and naphthyridine derivatives and pharmaceutical compositions
BG106390A (en) Novel spiro compounds
ATE82966T1 (de) Pyridincarboxamid-derivate und ihre verwendung als fungizides mittel.
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
DE69716925D1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
PT867436E (pt) Derivados de n-aril-piperidina e sua utilizacao como ligandos do receptor 5-ht1b
ATE113282T1 (de) Heteroaryl piperazine als antipsychotische mittel.
NO934718D0 (no) Nye HIV protease inhibitorer
DE69231422D1 (de) Pyridoncarbonsäurederivate
ATE159728T1 (de) Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung
YU83993A (sh) Novi derivati piridon organske kiseline
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
ATE209633T1 (de) Pyridinderivate,als arzneimittel zur behandlung von geschwüren und als antibakterielle mittel
MXPA02011234A (es) Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas.
ATE279191T1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
DE69017627D1 (de) Isochinolinderivate und ihre Salze als Proteasehemmer.
ATE275560T1 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
ATE141918T1 (de) Isoquinolinderivate
ES2090056T3 (es) Derivados de pirroloquinolina, su utilizacion como agentes antimicrobianos y procedimientos para su preparacion.